In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Perfect, J R, Cox, G M, Dodge, R K, Schell, W A
Multiple isolates of Cryptococcus neoformans were tested to compare the in vitro activity of a new triazole, SCH56592, with those of amphotericin B, fluconazole, and itraconazole, MICs of each drug...
Del Poeta, M, Schell, W A, Perfect, J R
The in vitro activity of the new antifungal drug pneumocandin L-743,872 against 55 isolates of clinically important molds was examined by an adapted macrobroth dilution method for yeasts....
Cameron, M L, Schell, W A, Bruch, S, Bartlett, J A, Waskin, H A, Perfect, J R
Yeast strains isolated from the oropharynx of 87 consecutive patients infected with human immunodeficiency virus type 1 were examined for in vitro susceptibility to fluconazole. Candida albicans was...
Fatal, disseminated Acremonium strictum infection in a neutropenic host.
Disseminated Acremonium strictum infection in a neutropenic patient is reported. Positive fecal cultures preceded positive cutaneous and blood cultures by 18 and 21 days, respectively, which suggests...
First report of involvement of Nodulisporium species in human disease.
Cox, G M, Schell, W A, Scher, R L, Perfect, J R
Allergic fungal sinusitis is a common disease that results from a hypersensitivity reaction mounted by the host against fungi living in the paranasal sinuses. We have recently treated a patient with...
In Vitro and In Vivo Efficacies of the New Triazole Albaconazole against Cryptococcus neoformans
Miller, J. L., Schell, W. A., Wills, E. A., Toffaletti, D. L., Boyce, M., Benjamin, D. K., ...
The activity of albaconazole (UR-9825; J. Uriach & Cía. S.A., Barcelona, Spain) was compared to that of fluconazole against 12 isolates of Cryptococcus neoformans in vitro and against 1 isolate in...
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Perfect, J R, Cox, G M, Dodge, R K, Schell, W A
Multiple isolates of Cryptococcus neoformans were tested to compare the in vitro activity of a new triazole, SCH56592, with those of amphotericin B, fluconazole, and itraconazole, MICs of each drug...
Del Poeta, M, Schell, W A, Perfect, J R
The in vitro activity of the new antifungal drug pneumocandin L-743,872 against 55 isolates of clinically important molds was examined by an adapted macrobroth dilution method for yeasts....
Cameron, M L, Schell, W A, Bruch, S, Bartlett, J A, Waskin, H A, Perfect, J R
Yeast strains isolated from the oropharynx of 87 consecutive patients infected with human immunodeficiency virus type 1 were examined for in vitro susceptibility to fluconazole. Candida albicans was...
Fatal, disseminated Acremonium strictum infection in a neutropenic host.
Disseminated Acremonium strictum infection in a neutropenic patient is reported. Positive fecal cultures preceded positive cutaneous and blood cultures by 18 and 21 days, respectively, which suggests...
First report of involvement of Nodulisporium species in human disease.
Cox, G M, Schell, W A, Scher, R L, Perfect, J R
Allergic fungal sinusitis is a common disease that results from a hypersensitivity reaction mounted by the host against fungi living in the paranasal sinuses. We have recently treated a patient with...
In Vitro and In Vivo Efficacies of the New Triazole Albaconazole against Cryptococcus neoformans
Miller, J. L., Schell, W. A., Wills, E. A., Toffaletti, D. L., Boyce, M., Benjamin, D. K., ...
The activity of albaconazole (UR-9825; J. Uriach & Cía. S.A., Barcelona, Spain) was compared to that of fluconazole against 12 isolates of Cryptococcus neoformans in vitro and against 1 isolate in...